Patient Characteristics
. | MEL100 . | MP . | . |
---|---|---|---|
No. of patients | 71 | 71 | |
Age | |||
<60 yrs | 18 | 18 | |
>60 yrs | 53 | 53 | |
β2-microglobulin | Matching criteria | ||
<3 mg/L | 19 | 19 | |
>3 mg/L | 52 | 52 | |
% of patients | |||
Stage at diagnosis | |||
II | 25 | 28 | |
III | 75 | 72 | |
Isotype | |||
IgG | 58 | 68 | |
IgA | 21 | 22 | |
Bence Jones protein | 21 | 10 | |
Creatinine >2 mg/dL | 6 | 11 | |
Hemoglobin <10 g/dL | 40 | 47 | |
Labeling index >1.2% | 28 | 30 | |
Bone marrow plasmocytosis >30% | 62 | 64 | |
Performance status >3 | 54 | 56 |
. | MEL100 . | MP . | . |
---|---|---|---|
No. of patients | 71 | 71 | |
Age | |||
<60 yrs | 18 | 18 | |
>60 yrs | 53 | 53 | |
β2-microglobulin | Matching criteria | ||
<3 mg/L | 19 | 19 | |
>3 mg/L | 52 | 52 | |
% of patients | |||
Stage at diagnosis | |||
II | 25 | 28 | |
III | 75 | 72 | |
Isotype | |||
IgG | 58 | 68 | |
IgA | 21 | 22 | |
Bence Jones protein | 21 | 10 | |
Creatinine >2 mg/dL | 6 | 11 | |
Hemoglobin <10 g/dL | 40 | 47 | |
Labeling index >1.2% | 28 | 30 | |
Bone marrow plasmocytosis >30% | 62 | 64 | |
Performance status >3 | 54 | 56 |